Aug 16, 20221 min readPlease join us for a clinical overview of VORAXAZE ~ 9/7/22 @6:30pmClick here to register!
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3
Comentarios